174
Views
5
CrossRef citations to date
0
Altmetric
Articles

Elevated levels of inflammatory markers in women with rheumatoid arthritis

ORCID Icon, &

References

  • Smolen, J. S.; Aletaha, D.; McInnes, I. B. Rheumatoid Arthritis. Lancet. 2016, 388, 2023–2038. DOI: 10.1016/S0140-6736(16)30173-8.
  • Nagayoshi, B. A.; Lourenção, L. G.; Kobayase, Y. N. S.; Paula, P. M. S.; Miyazaki, M. C. O. S. Rheumatoid Arthritis: Profile of Patients and Burden of Caregivers. Rev. Bras. Geriatr. Gerontol. 2018, 21, 44–52. DOI: 10.1590/1981-22562018021.170103.
  • Mcinnes, I. B.; Schett, G. Pathogenetic Insights from the Treatment of Rheumatoid Arthritis. Lancet. 2017, 389, 2328–2337. DOI: 10.1016/S0140-6736(17)31472-1.
  • Azevedo, A. F. B.; Petribú, K. C. L. D.; Lima, M. D. N.; Silva, A. S. D.; Rocha Filho, J. D. A.; Mariano, M. H. Q. D. A.; Rushansky, E. Quality of Life of Patients with Rheumatoid Arthritis under Biological Therapy. Rev. Assoc. Med. Bras. 2015, 61, 126–131. DOI: 10.1590/1806-9282.61.02.126.
  • Costa, J. D. O.; Almeida, A. M.; Guerra Jr, A. A.; Cherchiglia, M. L.; Andrade, E. I. G.; Acurcio, F. D. A. Tratamento Da Artrite Reumatoide No Sistema Único De Saúde, Brasil: Gastos Com Infliximabe Em Comparação Com Medicamentos Modificadores Do Curso Da Doença Sintéticos, 2003 a 2006. Cad Saude Publica. 2014, 30, 283–295.
  • Carvalho, C. S.; Andrade, L. E. C.; Keusseyan, S. P.; Rangel, J. L.; Ferreira-Strixino, J.; Martin, A. A.; Raniero, L. J. Study of Advanced Rheumatoid Arthritis. Rev. Bras. Eng. Biomed. 2014, 30, 54–63. DOI: 10.4322/rbeb.2014.004.
  • Guo, Z. Y.; Zhang, J. X.; Wu, M.; Mei, Y. F.; Lin, X. J.; Bu, C.; Xie, Y.; Wang, J. Meta-analysis of the Association between PADI4-92C/G Polymorphism and Rheumatoid Arthritis in the Chinese Population. Braz. J. Med. Biol. Res. 2017, 50(10). DOI: 10.1590/1414-431x20176115.
  • Sun, Q.; Hua, D. J.; Huang, S. C.; Cen, H.; Zhou, L.; Shao, S. Association Study of AFF1 Rs340630 Polymorphism with Genetic Susceptibility to Rheumatoid Arthritis in Chinese Population. Braz. J. Med. Biol. Res. 2018, 51, e7126. DOI: 10.1590/1414-431x20187126.
  • Brzustewicz, E.; Bryl, E. The Role of Cytokines in the Pathogenesis of Rheumatoid Arthritis—Practical and Potential Application of Cytokines as Biomarkers and Targets of Personalized Therapy. Cytokine. 2015, 76, 527–536. DOI: 10.1016/j.cyto.2015.08.260.
  • Mcinnes, I. B.; Buclkey, C. D.; Isaacs, J. D. Cytokines in Rheumatoid Arthritis – Shaping the Immunological Landscape. Nat. Rev. Rheumatol. 2015, 12, 63–68. DOI: 10.1038/nrrheum.2015.171.
  • Ursini, F.; D’Angelo, S.; Russo, E.; Arturi, F.; D’Antona, L.; Bruno, C.; Naty, S.; De Sarro, G.; Olivieri, I.; Grembiale, R. D. Serum Complement C3 Strongly Correlates with Whole-body Insulin Sensitivity in Rheumatoid Arthritis. Clin. Exp. Rheumatol. 2017, 35, 18–23. DOI: 10.1371/journal.pone.0163464.
  • Roeleveld, D. M.; Koenders, M. I. The Role of the TH17 Cytokines IL-17 and IL-22 in Rheumatoid Arthritis Pathogenesis and Developments in Cytokine Immunotherapy. Cytokine. 2014, 74, 101–107. DOI: 10.1016/j.cyto.2014.10.006.
  • Benedetti, G.; Miossec, P. Interleukin 17 Contributes to the Chronicity of Inflammatory Diseases Such as Rheumatoid Arthritis. Eur. J. Immunol. 2014, 44, 339–347. DOI: 10.1002/eji.201344184.
  • Vitale, R. F.; Ribeiro, F. A. Q. The Role of Tumor Necrosis Factor-alpha (tnf-alpha) in Bone Resorption Present in Middle Ear Cholesteatoma. Rev. Bras. Otorrinolaringol. 2007, 73, 123–127. DOI: 10.1590/S0034-72992007000100020.
  • Wei, S. T.; Sun, Y. H.; Zong, S. H.; Xiang, Y. B. Serum Levels of IL-6 and TNF-α May Correlate with Activity and Severity of Rheumatoid Arthritis. Medi. Sci. Monit. 2015, 21, 4030–4038. DOI: 10.12659/MSM.895116.
  • Page, M. J.; Bester, J.; Pretorius, E. The Inflammatory Effects of TNF-α and Complement Component 3 on Coagulation. Sci. Report. 2018, 8, 1812. DOI: 10.1038/s41598-018-20220-8.
  • Copenhaver, M.; Yu, C. Y.; Hoffman, R. P. Complement Components, C3 and C4, and the Metabolic Syndrome. Current Diabetes Rev. 2019, 15, 44–48. DOI: 10.2174/1573399814666180417122030.
  • Medeiros, M. M. C.; Oliveira, B. M. G. B.; Cerqueira, J. V. M.; Quixadá, R. T. S.; Oliveira, I. M. X. Correlação Dos Índices De Atividade Da Artrite Reumatoide (Disease Activity Score 28 Medidos Com VHS, PCR, Simplified Disease Activity Index E Clinical Disease Activity Index) E Concordância Dos Estados De Atividade Da Doença Com Vários Pontos De Corte Numa População Do Nordeste Brasileiro. Rev. Bras. Reumatol. 2015, 55(6), 477–484. DOI: 10.1016/j.rbr.2014.12.005.
  • Pernambuco, A. P.; Carvalho, L. S. C.; Schetino, L. P. L.; Polese, J. C.; Viana, R. S.; Reis, D. A. Effects of a Health Education Program on Cytokines and Cortisol Levels in Fibromyalgia Patients: A Randomized Controlled Trial. Adv. Rheumatol. 2018, 58, 21. DOI: 10.1186/s42358-018-0022-z.
  • Faleiro, L. R.; Araújo, L. H. R.; Varavallo, M. A. A Terapia anti-TNF-A Na Artrite Reumatoide. Semina: Ciências Biológicas E Da Saúde. 2011, 32, 77–94. DOI: 10.5433/1679-0367.2011v32n1p77.
  • Baptista, T. S. A.; Papel dos autoanticorpos contra proteínas do sistema nervoso no desempenho cognitivo de pacientes com artrite reumatoide. MS Dissertation, Pontifícia Universidade Católica do Rio Grande do Sul, Rio Grande do Sul, R.S./Brazil, 2016.
  • Halpern, M. T.; Cifaldi, M. A.; Kvien, T. K. Impact of Adalimumab on Work Participation in Rheumatoid Arthritis: Comparison of an Open – Label Extension Study and a Registry – Based Control Group. Ann. Rheum. Dis. 2008, 68, 930–937. DOI: 10.1136/ard.2008.092734.
  • Mota, L. M. H.; Cruz, B. A.; Albuquerque, C. P.; Gonçalves, D. P.; Laurindo, I. M. M.; Pereira, I. A.; Carvalho, J. F.; Pinheiro, G. R. C.; Bertolo, M. B.; Pinto, M. R. C.; et al. Posicionamento Sobre O Uso De Tofacitinibe No Algoritmo Do Consenso 2012 Da Sociedade Brasileira De Reumatologia Para O Tratamento Da Artrite Reumatoide. Rev. Bras. Reumatol. 2015, 55, 512–521. DOI: 10.1016/j.rbr.2015.08.004.
  • Castro‐Santos, P.; Díaz‐Peña, R. Genética Da Artrite Reumatoide: É Necessário Um Novo Impulso Em Populações Latino‐americanas. Rev. Bras. Reumatol. 2016, 56, 171–177. DOI: 10.1016/j.rbr.2015.08.009.
  • MacGregor, A. J.; Snieder, H.; Rigby, A. S.; Koskenvuo, M.; Kaprio, J.; Aho, K.; Silman, A. J. Characterizing the Quantitative Genetic Contribution to Rheumatoid Arthritis Using Data from Twins. Arthritis Rheum. 2000, 43, 30–37. DOI: 10.1002/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B.
  • Van Der Helm-Van, A. H. M.; Toes, R. E. M.; Huizinga, T. W. J. Genetic Variants in the Prediction of Rheumatoid Arthritis. Ann. Rheum. Dis. 2010, 69. 1694–1696. annrheumdis123828. DOI:10.1136/ard.2009.123828.
  • Al-Saadany, H. M.; Hussein, M. S.; Gaber, R. A.; Zaytoun, H. A. Th-17 Cells and Serum IL-17 in Rheumatoid Arthritis Patients: Correlation with Disease Activity and Severity. Egypt. Rheumatologist. 2016, 38, 1–7. DOI: 10.1016/j.ejr.2015.01.001.
  • Jain, M.; Attur, M.; Furer, V.; Todd, J.; Ramirez, R.; Lock, M.; Lu, Q. A.; Abramson, S. B.; Greenberg, J. D. Increased Plasma IL-17F Levels in Rheumatoid Arthritis Patients are Responsive to Methotrexate, anti-TNF, and T Cell Costimulatory Modulation. Inflammation. 2015, 38, 180–186. DOI: 10.1007/s10753-014-0020-1.
  • Hemdan, N. Y. A.; Birkenmeier, G.; Wichmann, G.; El-Saad, A. M. A.; Krieger, T.; Conrad, K.; Sack, U. Interleukin-17-producing T Helper Cells in Autoimmunity. Autoimmun. Rev. 2010, 9, 785–792. DOI: 10.1016/j.autrev.2010.07.003.
  • Hölttä, V.; Klementti, P.; Sipponen, T.; Westerholm-Ormio, M.; Kociubinski, G.; Salo, H.; Räsänen, L.; Kolho, K. L.; Färkkilä, M.; Savilahti, E.; et al. IL-23/IL-17 Immunity as a Hallmark of Crohn’s Disease. Inflamm. Bow. Dis. 2008, 14, 1175–1184. DOI: 10.1002/ibd.20475.
  • Tang, S.; Fan, X.; Pan, Q.; Sun, Q.; Liu, Y. Decreased Expression of IL-27 and Its Correlation with Th1 and TH17 Cells in Progressive Multiple Sclerosis. J. Neurol. Sci. 2015, 348, 174–180. DOI: 10.1016/j.jns.2014.11.035.
  • Rumzhum, N. N.; Patel, B. S.; Prabhala, P.; Gelissen, I. C.; Oliver, B. G.; Ammit, A. J. IL-17A Increases TNF-α Induced COX-2 Protein Stability and Augments PGE2 Secretion from Airway Smooth Muscle Cell: Impact on β2- Adrenergic Receptor Desensitization. Allergy. 2016, 71, 387–396. DOI: 10.1111/all.12810.
  • Monasterio, G.; Castillo, F.; Rojas, L.; Cafferata, E. A.; Alvarez, C.; Carvajal, P.; Núñez, C.; Flores, G.; Díaz, W.; Vernal, R. Th1/TH17/Th22 Immune Response and Their Association with Joint Pain, Imagenological Bone Loss, RANKL Expression, and Osteoclast Activity in Temporomandibular Joint Osteoarthritis. A Preliminar Report. J. Ora. Rehabil. 2018, 45. DOI: 10.1111/joor.12649.
  • Dhaouadi, T.; Chahbi, M.; Haouami, Y.; Sfar, I.; Abdelmoula, L.; Ben Abdallah, T.; Gorgi, Y. IL-17A, IL-17RC Polymorphisms and IL17 Plasma Levels in Tunisian Patients with Rheumatoid Arthritis. PLoS One. 2018, 13, e0194883. DOI: 10.1371/journal.pone.0194883.
  • Marwa, O. S.; Kalthoum, T.; Wajih, K.; Kamel, H. Association of IL17A and IL17F Genes with Rheumatoid Arthritis Disease and the Impact of Genetic Polymorphisms on Response to Treatment. Immunol. Lett. 2017, 183, 24–36. DOI: 10.1016/j.imlet.2017.01.013.
  • Kobayashi, T.; Murasawa, A.; Yokoyama, T.; Ishida, K.; Abe, A.; Yamamoto, K.; Yoshie, H. Serum Cytokine and Periodontal Profiles in Relation to Disease Activity of Rheumatoid Arthritis in Japanese Adults. J. Periodontol. 2010, 81, 650–657. DOI: 10.1902/jop.2010.090688.
  • Havemose-Poulsen, A.; Sorensen, L. K.; Stoltze, K.; Bendtzen, K.; Holmstrup, P. Cytokine Profiles in Peripheral Blood and Whole Blood Cell Cultures Associated with Aggressive Periodontitis, Juvenile Idiopathic Arthritis, and Rheumatoid Arthritis. J. Periodontol. 2005, 76, 2276–2285. DOI: 10.1902/jop.2005.76.12.2276.
  • Sherwood, E. R.; Toliver-Kinsky, T. Mechanisms of the Inflammatory Response. Best. Pract. Res. Clin. Anaesthesiol. 2004, 18, 385–405. DOI: 10.1016/j.bpa.2003.12.002.
  • Hitchon, C. A.; El-Gabalawy, H. S. The Synovium in Rheumatoid Arthritis. Open Rheumatol. J. 2011, 5, 107–114. DOI: 10.2174/1874312901105010107.
  • Jung, S. M.; Kim, K. W.; Yang, C. W.; Park, S. H.; Ju, J. H. Cytokine-mediated Bone Destruction in Rheumatoid Arthritis. J. Immunol. Res. 2014, 2014, 263625. DOI: 10.1155/2014/263625.
  • Shaker, O. G.; Alnoury, A. M.; Hegazyb, G. A.; El Haddad, H. E.; Sayed, S.; Hamdy, A. Polimorfismos Dos Genes Metilenotetrahidrofolato Redutase, Fator De Crescimento Transformador β1 E linfotoxina-α E Susceptibilidade À Artrite Reumatoide. Rev. Bras. Reumatol. 2016. DOI: 10.1016/j.rbr.2016.03.005.
  • Gottenberg, J. E.; Brocq, O.; Perdriger, A.; Lassoued, S.; Berthelot, J. M.; Wendling, D.; Euller-Ziegler, L.; Soubrier, M.; Richez, C.; Fautrel, B.;, et al. Non–TNF-targeted Biologic Vs a Second anti-TNF Drug to Treat Rheumatoid Arthritis in Patients with Insufficient Response to a First anti-TNF Drug: A Randomized Clinical Trial. Jama 2016, 316, 1172–1180. DOI: 10.1001/jama.2016.13512.
  • Nguyen, D. X.; Ehrenstein, M. R. Anti-TNF Drives Regulatory T Cell Expansion by Paradoxically Promoting Membrane TNF–TNF-RII Binding in Rheumatoid Arthritis. J. Exp. Med. 2016, 213, 1241–1253. DOI: 10.1084/jem.20151255.
  • Ursini, F.; D’Angelo, S.; Russo, E.; Ammerata, G.; Abenavoli, L.; Mauro, D.; Bruno, C.; Naty, S.; Grembiale, R. D.; Olivieri, I.; et al. Serum Complement C3 and Type 2 Diabetes in Rheumatoid Arthritis: A Case-control Study. Rev. Recent. Clin. Trials 2018, 13, 215–221. DOI: 10.2174/1574887113666180314092757.
  • Nydegger, U. E.; Zubler, R. H.; Gabay, R.; Joliat, G.; Karagevrekis, C. H.; Lambert, P. H.; Miescher, P. A. Circulating Complement Breakdown Products in Patients with Rheumatoid Arthritis. Correlation between Plasma C3d, Circulating Immune Complexes, and Clinical Activity. J. Clin. Invest. 1977, 59, 862–868. DOI: 10.1172/JCI108708.
  • Ballanti, E.; Perricone, C.; Di Muzio, G.; Kroegler, B.; Chimenti, M. S.; Graceffa, D.; Perricone, R. Role of the Complement System in Rheumatoid Arthritis and Psoriatic Arthritis: Relationship with anti-TNF Inhibitors. Autoimmun. Rev. 2011, 10, 617–623. DOI: 10.1016/j.autrev.2011.04.012.
  • Ricklin, D.; Lambris, J. D. Complement in Immune and Inflammatory Disorders: Pathophysiological Mechanisms. J. Immunol. 2013, 190, 3831–3838. DOI: 10.4049/jimmunol.1203487.
  • Chen, S.; Ma, B.; Cao, M.; Yu, H. Correlation among Serum MBL, MASP-2, HsCRP and C3 Levels in Rheumatoid Arthritis. Nan Fang Yi Ke Da Xue Xue Bao. 2016, 36, 1340–1344.
  • Di Muzio, G.; Perricone, C.; Ballanti, E.; Kroegler, B.; Greco, E.; Novelli, L.; Conigliaro, P.; Cipriani, P.; Giacomelli, R.; Perricone, R. Complement System and Rheumatoid Arthritis: Relationships with Autoantibodies, Serological, Clinical Features, and anti-TNF Treatment. Int. J. Immunopathol. Pharmacol. 2011, 24, 357–366. DOI: 10.1177/039463201102400209.
  • Ursini, F.; Russo, E.; Mauro, D.; Abenavoli, L.; Ammerata, G.; Serrao, A.; Grembiale, R. D.; De Sarro, G.; Olivieri, I.; D’angelo, S. Complement C3 and Fatty Liver Disease in Rheumatoid Arthritis Patients: A Cross-sectional Study. Eur. J. Clin. Invest. 2017, 47(10), 728–735. DOI: 10.1111/eci.12798.
  • Wang, T.; Li, S.; Yang, Y.; Zhang, K.; Dong, S.; Wang, X.; Liu, X.; Ren, Y.; Zhang, M.; Yan, X.; et al. T Helper 17 and T Helper 1 Cells are Increased but Regulatory T Cells are Decreased in Subchondral Bone Marrow Microenvironment of Patients with Rheumatoid Arthritis. Am. J. Tourism Res. 2016, 8, 2956e2968.
  • Zhong, W.; Zhao, L.; Liu, T.; Jiang, Z. IL-22-producing Cd4þt Cells in the Treatment Response of Rheumatoid Arthritis to Combination Therapy with Methotrexate and Leflunomide. Sci. Rep. 2017, 7, 41143.
  • Boytsov, N.; Harrold, L. R.; Mason, M. A.; Gaich, C. L.; Zhang, X.; Larmore, C. J.; Rebello, S.; Araujo, A. B. Increased Healthcare Resource Utilization in Higher Disease Activity Levels in Initiators of TNF Inhibitors among US Rheumatoid Arthritis Patients. Curr. Med. Res. Opin. 1959–1967, 2016(32). DOI: 10.1080/03007995.2016.1222515.
  • Kopciuch, D.; Paczkowska, A.; Leszczynsk, P.; Michalak, M.; Nowakowskai, E. Effect of Therapy with anti-TNF-α Drugs and DMARD on Disease Activity and Health Related Quality of Life among Women with Rheumatoid Arthritis. Acta. Pol. Pharm. 2016, 73, 547–554.
  • Li, W.; Li, H.; Song, W.; Hu, Y.; Liu, Y.; Da, R.; Chen, X.; Li, Y.; Ling, H.; Zhong, Z.; et al. Differential Diagnosis of Systemic Lupus Erythematosus and Rheumatoid Arthritis with Complements C3 and C4 and C-reactive Protein. Exp. Ther. Med. 2013, 6, 1271–1276.
  • Schulze, C.; Munoz, L. E.; Franz, S.; Sarter, K.; Chaurio, R. A.; Gaipl, U. S.; Herrmann, M. Clearance Deficiency – A Potential Link between Infections and Autoimmunity. Autoimmun. Rev. 2008, 8, 5–8.
  • França, S. C. O.; Artrite reumatóide: terapêutica atual e perspectivas futuras. Dissertation, Universidade Lusófona de Humanidades e Tecnologias, Lisbon, Portugal, 2018.
  • Bachiega, T. F.; Produção de citocinas pró- e anti-inflamatórias por macrófagos estimulados in vitro com própolis, alecrim-do-campo, capim-limão e cravo-da índia. MS Dissertation, Universidade Estadual Paulista – UNESP, São Paulo, SP, 2011.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.